STRATA Skin Sciences to Present at the Lytham Partners Spring 2021 Investor Conference
HORSHAM, Pa., March 16, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA”) (NASDAQ: SSKN), a medical technology company in...
News
Oncology Pharma Reveals Strategic Plans for Company Growth and Focus
SAN FRANCISCO, CA, March 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Oncology Pharma, Inc. (OTC: ONPH) revealed today the...
F-star Therapeutics to Host Full-Year 2020 Investor Call and Provide Corporate Update on March 29, 2021
CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., March 16, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company...
aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2020 Financial Results
Management to host conference call and webcast on March 23rd at 5:00 pm EDT / 2:00 pm PDTSAN DIEGO, March...
Prelude Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Operational Update
– Dose Escalation Portion of Phase 1 Trial of PRT543 Complete; Additional Expansion Cohorts Set to Initiate Early in the...
Acepodia Completes $47 Million Series B Financing to Advance Pipeline of Allogeneic Cell Therapy Candidates
Programs receiving funding include those developing company’s proprietary cryopreserved NK and gamma delta T-cell candidatesSAN MATEO, Calif., March 16, 2021...
NeuBase Therapeutics to Present at the 2021 Muscular Dystrophy Association Virtual Clinical & Scientific Conference
PITTSBURGH, March 16, 2021 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (NASDAQ: NBSE) (“NeuBase” or the “Company”), a biotechnology company accelerating...
Icario Appears on Inc. Magazine’s List of the Midwest’s Fastest-Growing Private Companies
Companies on the 2021 Inc. 5000 Regionals: Midwest list employed more than 43,000 peopleMINNEAPOLIS, March 16, 2021 (GLOBE NEWSWIRE) --...
Innovative Cellular Therapeutics Appoints Eugene Kennedy as Chief Medical Officer
ROCKVILLE, Md., March 16, 2021 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics (ICT), a clinical stage biotechnology company developing a comprehensive...
VistaGen Therapeutics to Participate in Upcoming Investor Conferences in March
SOUTH SAN FRANCISCO, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company committed to developing...
Aleafia Health Expands Adult-Use Presence with Entrance in Saskatchewan, New Provincial Market
TORONTO, March 16, 2021 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is...
Nephros to Present at the Q1 Virtual Investor Summit
SOUTH ORANGE, N.J., March 16, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology...
Roche Annual General Meeting 2021
All proposals of the Board of Directors approvedChristoph Franz re-elected as Chairman of the Board of Directors; all current Board...
Aptose Expands Senior Leadership Team
George Melko, Pharm.D. joins as Vice President, Regulatory Affairs Robert Killion, Ph.D. appointed Vice President, CMC SAN DIEGO and TORONTO,...
Large Southwestern Health System Signs New Contract for Streamline Health® eValuator™
Automated Coding Analysis for Inpatient and Outpatient Care Atlanta, GA, March 16, 2021 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc....
Iterum Therapeutics Appoints Beth P. Hecht to Board of Directors
Patrick Heron to leave the Board DUBLIN, Ireland and CHICAGO, March 16, 2021 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq:...
Evaxion Biotech Announces Publication of Study on S. aureus Bacterium in Scientific Reports
COPENHAGEN, Denmark, March 16, 2021 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX), a clinical-stage biotechnology company specializing in the...
Iridia Raises $24 Million in Series B Funding
Oversubscribed Financing to Build World’s First High-Density DNA-Based Memory ChipSAN DIEGO, March 16, 2021 (GLOBE NEWSWIRE) -- Iridia™, Inc., a...
Arbutus Receives Regulatory Approval to Initiate a Phase 1a/1b Clinical Trial with AB-836, an Oral Capsid Inhibitor for the Treatment of Chronic Hepatitis B Infection
WARMINSTER, Pa., March 16, 2021 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company primarily focused on developing...
Jubilant Radiopharma and Isotopia Molecular Imaging Enter into a Strategic Partnership to Further Advance the Field of Radiotherapeutics
Yardley, Pennsylvania--(Newsfile Corp. - March 16, 2021) - Isotopia Molecular Imaging Limited (Isotopia) and Jubilant Radiopharma, a business division of...